Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00066651 | Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00019110 | Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT01790204 |
| A Study of the Effects of PEITC on Oral Cells With Mutant p53 |
| completed |
| Phase 1 / Phase 2 |
| 55 |
| Georgetown UniversityOTHER |
| 1 |
| Mar 23, 2015 |
| clinicaltrials |
| NCT01334177 | TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck | completed | Phase 1 | 13 | University of WashingtonOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT01379339 | Cabazitaxel - PF Induction Chemotherapy | completed | Phase 1 | 40 | Krzysztof MisiukiewiczOTHER | 1 | Feb 11, 2015 | clinicaltrials |
| NCT01219673 | Symptom Burden in Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 10, 2015 | clinicaltrials |
| NCT00738751 | Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers | completed | Phase 1 | 44 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 4, 2015 | clinicaltrials |
| NCT00354523 | Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma | terminated | Phase 1 / Phase 2 | 21 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 17, 2014 | clinicaltrials |
| NCT00968656 | Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1(FISO PET/CT) | completed | Phase 1 | 31 | Washington University School of MedicineOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT01283334 | A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer | completed | Phase 1 / Phase 2 | 20 | Emory UniversityOTHER | 1 | Dec 4, 2014 | clinicaltrials |
| NCT01462903 | A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 1 | 20 | Sun Yat-sen UniversityOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT01088763 | Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia | terminated | Phase 1 | 129 | National Cancer Institute (NCI)NIH | 2 | Nov 5, 2014 | clinicaltrials |
| NCT00027534 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 14 | Michael Morse, MDOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT00113334 | Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer | completed | Phase 1 / Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2014 | clinicaltrials |
| NCT02209701 | Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors | terminated | Phase 1 | 3 | Boehringer IngelheimINDUSTRY | 0 | Aug 6, 2014 | clinicaltrials |
| NCT02204033 | Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients With Head and Neck Cancer | completed | Phase 1 | 33 | Boehringer IngelheimINDUSTRY | 0 | Jul 30, 2014 | clinicaltrials |
| NCT00002947 | Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer | terminated | Phase 1 | 35 | Yale UniversityOTHER | 1 | Jul 2, 2014 | clinicaltrials |
| NCT01360827 | EMD 1201081 + 5-FU + Cisplatin + Cetuximab in Subjects With Recurrent / Metastatic Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | 13 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00049283 | Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2014 | clinicaltrials |
| NCT01741597 | Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung | withdrawn | Phase 1 | 0 | City of Hope Medical CenterOTHER | 1 | May 30, 2014 | clinicaltrials |
| NCT00841191 | A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors | completed | Phase 1 / Phase 2 | 84 | Centocor, Inc.INDUSTRY | 5 | May 14, 2014 | clinicaltrials |
| NCT00918762 | Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx | completed | Phase 1 | 6 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01712919 | Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) | completed | Phase 1 / Phase 2 | 61 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Mar 24, 2014 | clinicaltrials |
| NCT02055989 | A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx | completed | Phase 1 / Phase 2 | 105 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT01255800 | Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer | completed | Phase 1 | 9 | University of Colorado, DenverOTHER | 1 | Jan 31, 2014 | clinicaltrials |
| NCT01735409 | Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma(ABX-DDP-Dose) | unknown | Phase 1 / Phase 2 | 69 | Sun Yat-sen UniversityOTHER | 1 | Jan 28, 2014 | clinicaltrials |
| NCT00004062 | Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer | completed | Phase 1 | — | Lucille P. Markey Cancer Center at University of KentuckyOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT01728480 | Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Dec 11, 2013 | clinicaltrials |
| NCT02004795 | BNCT and IG-IMRT for Recurrent Head and Neck Cancer | unknown | Phase 1 / Phase 2 | 28 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Dec 9, 2013 | clinicaltrials |
| NCT00003182 | Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck | unknown | Phase 1 / Phase 2 | 40 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00003251 | Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer | unknown | Phase 1 / Phase 2 | 46 | University of Illinois at ChicagoOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00004226 | Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy | unknown | Phase 1 / Phase 2 | — | University of Alabama at BirminghamOTHER | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00055770 | Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01184482 | Lapatinib and Cetuximab in Patients With Solid Tumors(TYKERB-ITUX 1) | completed | Phase 1 | 22 | Georgetown UniversityOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT00243347 | The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 2 | Oct 17, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00049166 | Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00004097 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | unknown | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00103155 | Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer | unknown | Phase 1 | — | University of California, San FranciscoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT01100619 | A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors | completed | Phase 1 | 40 | ExelixisINDUSTRY | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT00858663 | Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer | completed | Phase 1 | 13 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00006106 | ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00906360 | Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00004901 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer | completed | Phase 1 / Phase 2 | — | Robert H. Lurie Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003430 | L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00005952 | Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors | completed | Phase 1 / Phase 2 | 30 | Duke UniversityOTHER | 1 | Jun 20, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 30, 2015source: clinicaltrials